A global leader in the development and manufacture of ophthalmic surgical devices.

Who are we?

MID Labs was founded by Dr. Carl Wang in 1981 and has been associated with vitreoretinal surgery from its infancy. Not only has MID Labs invented the tools for modern vitrectomy, but as a company, we have been instrumental in revolutionizing the ophthalmic field through our products.

MID Labs continues to innovate with the MID Labs branded product line which is supplied to more than 30 countries around the world. These products set the standard for precision, performance, and quality.

SAN LEANDRO, Calif. -- MID Labs, a leading global medical device company, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for a new vitrectomy cutter that uses proprietary cutter technology to help enhance the clinical experience during this important procedure.

MID Labs Closed a $51MM Round of Financing Led by OrbiMed and Frontline BioVentures

October 16, 2014

SAN LEANDRO, Calif. -- MID Labs Ltd., a medical device company currently focused on developing novel products for vitreoretinal surgery, today announced the closing of $51 million of financing. This investment is led by OrbiMed and Frontline BioVentures. Other investors include Softbank China Venture Capital (SBCVC), Allen Chao, and Sungent BioVenture.